Navigation Links
Hughes Syndrome Mimics MS Causing Wrong Diagnosis

A former motorcycle racer, John Simper, 60, from Ipswich who had been diagnosed with multiple sclerosis (MS), 26 years ago believes// he could be saved from ending his life in a wheelchair.

Mr. Simper is now confident that he has been suffering from a condition known as Hughes Syndrome, which thickens the blood and slows down the brain. It was explained that this condition that had been discovered in 1993, imitates MS but has a very simple line of treatment with blood thinning drugs or aspirin.

Believing that many other people, would have also been diagnosed in the past with MS, might have Hughes Syndrome, Mr Simper has now started a campaign to make the condition better known. Simper also said that, “When I first heard about it I contacted my doctor and he had never heard of the condition.”

It has been reported that more than 150,000 people in the UK have the condition, which also causes recurrent miscarriages and chronic migraine. Hughes Syndrome causes the patient to suffer from abnormal movements, dizzy spells, short-term memory loss, headaches and angina.

Mr Simper explained that his problems began after he was seriously assaulted and knocked out in 1980, he had also many numerable injuries on all parts of the body due to his many crashes and accidents as a bike racer. He stated that he went through with his doctors the process of eliminating other condition and was finally diagnosed with MS.

He said, “The tests for MS are a matter of eliminating other conditions and I had nothing else. Then a few months ago my daughter drew my attention to an article about Hughes Syndrome. I'm wary of new developments in my condition but asked my doctor about it and he had never heard of it. Now I am doing all that I can to make people aware.”

He further stated, “I'm not jumping up and down with joy yet because I am going to have my first referral at St Thomas's Hospital in London, which is the main trea
'"/>




Page: 1 2

Related medicine news :

1. Early Clue to Down Syndrome
2. Hope For Stiff-Person Syndrome
3. Restless Legs Syndrome - Help at hand
4. Severe Acute respiratory Syndrome (SARS)
5. WHO Travel Advice to prevent spread of "Severe Acute Respiratory Syndrome (SARS)
6. Treatment for Syndrome X
7. “ Economy Class Syndrome
8. Dementia and Down Syndrome
9. Understanding Restless Legs Syndrome
10. A New Option for Patients Suffering From QT Syndrome
11. Individuals With Metabolic Syndrome At Risk of Dying From Heart Disease
Post Your Comments:
(Date:10/10/2008)...Coach Holly Warlick Teams Up with Legal and Medica...Ever Cancer and Careers Seminar in,Knoxville, KNO...ion of National,Breast Cancer Awareness Month, Can...e joined forces with YWCA Knoxville, The Wellness ...e Holly Warlick, University of Tennessee,women,s b...
(Date:10/10/2008)... The Healthcare Technology Ev... , Exton, PA (PRWEB) Sept...ey Chapters of the national Healthcare Information...forces to bring regional health information techno... conference entitled The Healthcare Technology Evo...
(Date:10/10/2008)...ston, MABoston Medical Center (BMC) has received a...l Institute on Aging (NIA) to fund the Boston Clau...BMC,s Pepper Center is one of only 11 Pepper Cente... Americans Independence Center Program was establi...enator from Florida. During his five decades of pu...
(Date:10/10/2008)...olecular CT adds metabolic information from PET to...gnostic imaging for maximized workflow ...ICH, Germany, Oct. 10 /PRNewswire/ -- Siemens Heal...duces molecular CT, a new concept in,integrated im...d is a,practical solution for today,s shrinking he...
Breaking Medicine News(10 mins):Health News:Local Experts Help Women Living and Working with Cancer Even the Score 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 3Health News:Local Experts Help Women Living and Working with Cancer Even the Score 4Health News:HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference 2Health News:Boston Medical Center receives $5.8m grant 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 3Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 4
...e world's leading pharmaceutical companies, issued...improves survival in patients// with metastatic pr...TAX 327 compared Taxotere plus prednisone to Novan...The study included a little over a thousand men wh...
...of malaria, one of the most common vector-borne di...ases in 2005 to 1.2 million cases in 2006, the Eco...ial sectors, the Economic Survey said malaria deat...o 961 people in the country in this period. Accor...
...r-pregnancy pounds should add daily walks and limi... by Harvard researchers. // “The childbearing year... women,” said lead author Emily Oken, M.D. “Modifi...m period — such as diet, television viewing and wa...
...oles in their eardrums could have better success r...ctors at West Virginia University. // The study wa...ngology – Head and Neck Surgery, the official jour...ngology-Head and Neck Surgery Foundation. Conducte...
Other Medicine News:Health News:Incidence of Malaria Has Come Down, Says Economic Survey 2Health News:Simple Solutions to Postpartum Weight Retention 2Health News:Inner-ear Volume Study Leads to Higher Surgery Success Rates 2
(Date:10/9/2008)... Top Line Clinical Results Expected in Novembe...all/ -- SCOLR Pharma, Inc.,(Amex: DDD ) announced...sing,for the third of its three pivotal trials to ...n of 12-hour extended-release (ER) ibuprofen for,t...cts to report top-line,results from this pivotal t...
(Date:10/8/2008)... - Findings May Someday Inform Treatments for ..., Oct. 8 /PRNewswire-USNewswire/ -- A protein that...r plays a key role in controlling,the developing n...s precise,connections to form among nerve cells ma...ents who suffer injuries to their nervous system,...
(Date:10/8/2008)... Findings Confirm Potency of Poly-ICR as...FirstCall/ -- Nventa Biopharmaceuticals,Corporatio...eclinical,studies using its proprietary Toll-like ...R), at the World Vaccine Congress 2008 in Lyon, Fr...potent vaccine adjuvant,targeting the Toll-like Re...
(Date:10/7/2008)... Study evaluates the efficacy of new device for de...issed during colonoscopy, ORLANDO, Fla., Oct. 7 /...terology Annual Scientific Meeting in Orlando (ACG..., MD presented results from a,multi-institutional ...Third,Eye(R) Retroscope(R), a new device that is d...
Breaking Medicine Technology:SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3Protein Shown to Play a Key Role in Normal Development of Nervous System 2Protein Shown to Play a Key Role in Normal Development of Nervous System 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5A South Florida Premiere 22160 1A South Florida Premiere 22160 2Nuvelo to Present at Jefferies 2nd Annual Healthcare Conference 22157 1Accuray Incorporateds CEO to Speak at Jefferies Second Annual Healthcare Conference 22154 1Accuray Incorporateds CEO to Speak at Jefferies Second Annual Healthcare Conference 22154 2BioSpace Launches EuroBio 28TM 29 Online Community 6074 1BioSpace Launches EuroBio 28TM 29 Online Community 6074 2
...also show evidence of additional protection,agains... LOS ANGELES, April 17, 2007 /PRNewswire-FirstCall... vaccine, CERVARIX(R),demonstrated 100 percent ef...ancer-causing human papillomavirus types 16 and 18...l, according to,data presented today at the Americ...
...USINESS WIRE)--Apr 17, 2007 - Adnexus(TM),Therapeu... abstract,"CT-322: A specific VEGFR-2-blocking pro...l tumor models comparable to pan-specific,tyrosine...b" at the,American Association for Cancer Research...e lead author is Irvith Carvajal, Ph.D., with,Eric...
Other Medicine Technology:Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 2Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 3Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 4Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 5Adnexus Therapeutics Announces Presentation at the American,Association for Cancer Research (AACR) on Clinical Product,Candidate, CT-322 2Adnexus Therapeutics Announces Presentation at the American,Association for Cancer Research (AACR) on Clinical Product,Candidate, CT-322 3Adnexus Therapeutics Announces Presentation at the American,Association for Cancer Research (AACR) on Clinical Product,Candidate, CT-322 4
Attain Left-heart Lead Delivery Systems. Medtronic offers left-heart lead delivery systems to assist with accessing the coronary sinus (cs).
Attain LV Leads. Navigate minimally angled veins with little to moderate tortuosity.
The Hancock Standard Mitral bioprosthesis is a portrait of dependability, with predictable results based on 25 years of clinical use. Documented long-term performance makes it an excellent choice for
Implantable defibrillators are used to treat heart rhythms that are abnormally fast and life threatening. Implantable cardioverter defibrillators (ICDs) often are used to treat sudden cardiac death (
Medicine Products: